grant

Development of DNA targeted platinum agents as potential anticancer drugs [ 2003 - 2005 ]

Also known as: Anticancer platinum drugs which act on DNA

Funded by National Health and Medical Research Council
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/251578]

Researchers: Dr William Mcfadyen (Principal investigator) ,  A/Pr Vincent Murray ,  Prof William Denny

Brief description A number of clinically useful anticancer drugs damage DNA. As a result of this damage these drugs kill cancer cells. This project aims to develop new platinum-containing compounds which are specifically targeted to DNA. Through this strategy it is possible that new and more useful anticancer drugs could emerge.

Funding Amount $AUD 410,250.00

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Anticancer Drug Discovery | Biomedical and Clinical Sciences | Cancer Chemotherapy | DNA Targeted Drugs | DNA Targeting | Drug Resistant Tumours | Medical Biochemistry and Metabolomics | Medical Biochemistry and Metabolomics Not Elsewhere Classified | Novel Covalent Platinum Lesions | Platinum DNA Adduct Detection By DNA Sequencing |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA